Inocucor has hired David Sisk as Senior Vice President, Finance and Administration & Chief Financial Officer.

David is an accomplished financial executive whose previous experience includes leadership roles in global organizations such as Armacell, Platform Specialty Products Corporation and Cheminova A/S. He is skilled in business strategy and process improvement, and guiding companies through mergers and acquisitions. He has a master’s in economics from North Carolina State University and is a certified public accountant (CPA NC).
 
Inocucor President and CEO Donald R Marvin said, “In the past year, Inocucor has moved from being an emerging startup to a going commercial enterprise. This newest addition to our executive leadership team will help guide the company as we build our business throughout the Americas and into Western Europe. David is a well-credentialed financial executive with extensive international experience, including strategic M&A.”
 
Inocucor produces microbial products based on a patented fermentation process that help improve plant health and productivity. Its products are safe for people and the environment and are in use by growers in Canada and the US The company has raised more than $50 million in private equity funds in the past three years.
 
In May, Inocucor will occupy its new 30,000-square-foot US headquarters and commercialization office currently under construction in Centennial, Colo. Its Montreal-based, R&D-focused Technical Center of Excellence is currently being enlarged from 10,000 to 20,000 square feet to house expanded product development and manufacturing operations. The company employs about 40 people in Montreal and the US, and anticipates adding another 25 to 30 high-level scientific and managerial professionals over the next year.